Adimmune Corp
TWSE:4142
Adimmune Corp
TWSE:4142
Price:
18
TWD
Market Closed
Market Cap:
NT$7.7B
Balance Sheet
Balance Sheet Decomposition
Adimmune Corp
Adimmune Corp
Balance Sheet Decomposition is not available for
Adimmune Corp
Adimmune Corp
Balance Sheet
Adimmune Corp
Adimmune Corp
Currency: TWD
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
69
|
648
|
1 096
|
882
|
950
|
1 096
|
507
|
859
|
943
|
1 670
|
1 235
|
627
|
1 054
|
4 087
|
2 652
|
2 857
|
2 458
|
2 345
|
|
| Cash |
0
|
0
|
0
|
0
|
215
|
322
|
160
|
859
|
943
|
1 670
|
1 235
|
547
|
974
|
3 827
|
2 382
|
2 522
|
1 967
|
1 762
|
|
| Cash Equivalents |
69
|
648
|
1 096
|
882
|
735
|
774
|
347
|
0
|
0
|
0
|
0
|
80
|
80
|
260
|
270
|
335
|
490
|
582
|
|
| Short-Term Investments |
7
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
29
|
52
|
350
|
239
|
116
|
13
|
113
|
|
| Total Receivables |
5
|
104
|
307
|
113
|
5
|
55
|
171
|
207
|
23
|
402
|
42
|
438
|
505
|
110
|
100
|
535
|
1 308
|
188
|
|
| Accounts Receivables |
3
|
100
|
303
|
102
|
0
|
54
|
163
|
194
|
21
|
402
|
42
|
438
|
505
|
110
|
100
|
534
|
1 308
|
188
|
|
| Other Receivables |
3
|
4
|
4
|
11
|
5
|
2
|
7
|
12
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Inventory |
174
|
135
|
262
|
248
|
189
|
168
|
305
|
372
|
494
|
508
|
638
|
491
|
428
|
302
|
506
|
659
|
526
|
628
|
|
| Other Current Assets |
50
|
146
|
117
|
108
|
105
|
126
|
63
|
81
|
86
|
143
|
122
|
147
|
301
|
198
|
299
|
324
|
395
|
337
|
|
| Total Current Assets |
305
|
1 035
|
1 783
|
1 351
|
1 250
|
1 446
|
1 046
|
1 669
|
1 545
|
2 727
|
2 037
|
1 732
|
2 340
|
5 047
|
3 796
|
4 491
|
4 699
|
3 610
|
|
| PP&E Net |
1 334
|
2 589
|
3 219
|
3 281
|
3 316
|
3 616
|
3 429
|
3 215
|
2 987
|
2 769
|
2 637
|
2 453
|
2 508
|
2 880
|
3 575
|
3 848
|
3 976
|
4 087
|
|
| PP&E Gross |
1 334
|
2 589
|
3 219
|
3 281
|
3 316
|
3 616
|
3 429
|
3 215
|
2 987
|
2 769
|
2 637
|
2 453
|
2 508
|
2 880
|
3 575
|
3 848
|
3 976
|
4 087
|
|
| Accumulated Depreciation |
135
|
158
|
251
|
444
|
635
|
857
|
1 100
|
1 345
|
1 589
|
1 833
|
2 075
|
2 300
|
2 481
|
2 665
|
2 779
|
2 993
|
3 171
|
3 321
|
|
| Intangible Assets |
395
|
513
|
560
|
657
|
612
|
565
|
518
|
468
|
420
|
373
|
199
|
167
|
143
|
139
|
117
|
93
|
70
|
48
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
137
|
327
|
335
|
335
|
|
| Long-Term Investments |
66
|
64
|
62
|
61
|
76
|
94
|
121
|
142
|
177
|
189
|
160
|
1 077
|
1 337
|
162
|
145
|
127
|
133
|
138
|
|
| Other Long-Term Assets |
73
|
91
|
85
|
68
|
349
|
286
|
373
|
363
|
306
|
727
|
712
|
248
|
242
|
245
|
240
|
263
|
270
|
263
|
|
| Total Assets |
2 172
N/A
|
4 291
+98%
|
5 709
+33%
|
5 417
-5%
|
5 602
+3%
|
6 006
+7%
|
5 487
-9%
|
5 857
+7%
|
5 435
-7%
|
6 785
+25%
|
5 746
-15%
|
5 678
-1%
|
6 570
+16%
|
8 473
+29%
|
8 010
-5%
|
9 149
+14%
|
9 484
+4%
|
8 481
-11%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
4
|
80
|
26
|
7
|
3
|
18
|
11
|
33
|
12
|
27
|
41
|
19
|
10
|
23
|
6
|
49
|
42
|
31
|
|
| Accrued Liabilities |
26
|
52
|
154
|
85
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
78
|
100
|
347
|
200
|
200
|
200
|
200
|
0
|
300
|
680
|
300
|
870
|
0
|
0
|
0
|
20
|
540
|
500
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
78
|
0
|
0
|
0
|
78
|
78
|
80
|
9
|
48
|
142
|
685
|
339
|
|
| Other Current Liabilities |
130
|
71
|
274
|
61
|
79
|
115
|
108
|
92
|
116
|
111
|
192
|
238
|
119
|
493
|
243
|
290
|
520
|
291
|
|
| Total Current Liabilities |
237
|
302
|
801
|
353
|
282
|
333
|
397
|
203
|
428
|
818
|
611
|
1 205
|
210
|
525
|
297
|
500
|
1 787
|
1 161
|
|
| Long-Term Debt |
0
|
770
|
1 137
|
1 001
|
1 735
|
1 921
|
1 843
|
1 180
|
1 300
|
2 809
|
2 724
|
2 613
|
2 531
|
1 314
|
1 273
|
2 101
|
1 918
|
1 758
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
270
|
249
|
216
|
240
|
214
|
180
|
313
|
284
|
421
|
303
|
329
|
|
| Other Liabilities |
10
|
7
|
4
|
1
|
9
|
14
|
8
|
7
|
21
|
63
|
61
|
4
|
4
|
5
|
8
|
2
|
2
|
1
|
|
| Total Liabilities |
247
N/A
|
1 079
+337%
|
1 942
+80%
|
1 355
-30%
|
2 025
+49%
|
2 268
+12%
|
2 249
-1%
|
1 659
-26%
|
1 998
+20%
|
3 906
+95%
|
3 636
-7%
|
4 035
+11%
|
2 925
-28%
|
2 157
-26%
|
1 861
-14%
|
3 025
+63%
|
4 010
+33%
|
3 249
-19%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
945
|
1 587
|
1 583
|
1 638
|
1 644
|
1 842
|
1 858
|
2 375
|
2 376
|
2 376
|
2 377
|
2 377
|
3 632
|
4 295
|
4 295
|
4 295
|
4 295
|
4 295
|
|
| Retained Earnings |
29
|
59
|
536
|
697
|
213
|
392
|
613
|
613
|
762
|
596
|
760
|
942
|
1 226
|
1 123
|
945
|
1 238
|
598
|
351
|
|
| Additional Paid In Capital |
1 038
|
1 713
|
1 648
|
1 727
|
1 729
|
2 280
|
1 979
|
2 438
|
1 828
|
1 085
|
494
|
76
|
1 137
|
830
|
855
|
849
|
835
|
829
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
83
|
0
|
68
|
138
|
103
|
68
|
54
|
35
|
39
|
49
|
|
| Treasury Stock |
29
|
29
|
0
|
0
|
0
|
0
|
0
|
50
|
89
|
83
|
68
|
7
|
0
|
0
|
0
|
293
|
293
|
293
|
|
| Other Equity |
0
|
0
|
0
|
0
|
9
|
9
|
13
|
0
|
0
|
96
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
1 925
N/A
|
3 212
+67%
|
3 767
+17%
|
4 062
+8%
|
3 578
-12%
|
3 738
+4%
|
3 237
-13%
|
4 198
+30%
|
3 436
-18%
|
2 879
-16%
|
2 110
-27%
|
1 643
-22%
|
3 645
+122%
|
6 316
+73%
|
6 149
-3%
|
6 124
0%
|
5 475
-11%
|
5 233
-4%
|
|
| Total Liabilities & Equity |
2 172
N/A
|
4 291
+98%
|
5 709
+33%
|
5 417
-5%
|
5 602
+3%
|
6 006
+7%
|
5 487
-9%
|
5 857
+7%
|
5 435
-7%
|
6 785
+25%
|
5 746
-15%
|
5 678
-1%
|
6 570
+16%
|
8 473
+29%
|
8 010
-5%
|
9 149
+14%
|
9 484
+4%
|
8 481
-11%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
174
|
174
|
174
|
174
|
175
|
196
|
198
|
251
|
249
|
249
|
250
|
252
|
363
|
430
|
430
|
422
|
422
|
422
|
|
Switch to:
Switch to:
See Also
Discover More
